TSBX vs. DTIL, VTVT, ESLA, ELEV, RAPT, CLNN, CASI, LTRN, TPST, and PASG
Should you be buying Turnstone Biologics stock or one of its competitors? The main competitors of Turnstone Biologics include Precision BioSciences (DTIL), vTv Therapeutics (VTVT), Estrella Immunopharma (ESLA), Elevation Oncology (ELEV), RAPT Therapeutics (RAPT), Clene (CLNN), CASI Pharmaceuticals (CASI), Lantern Pharma (LTRN), Tempest Therapeutics (TPST), and Passage Bio (PASG). These companies are all part of the "pharmaceutical products" industry.
Turnstone Biologics vs.
Precision BioSciences (NASDAQ:DTIL) and Turnstone Biologics (NASDAQ:TSBX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, community ranking, profitability, earnings and institutional ownership.
Precision BioSciences has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500. Comparatively, Turnstone Biologics has a beta of 2.14, indicating that its share price is 114% more volatile than the S&P 500.
38.0% of Precision BioSciences shares are owned by institutional investors. Comparatively, 52.5% of Turnstone Biologics shares are owned by institutional investors. 4.0% of Precision BioSciences shares are owned by insiders. Comparatively, 32.1% of Turnstone Biologics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Turnstone Biologics has lower revenue, but higher earnings than Precision BioSciences. Turnstone Biologics is trading at a lower price-to-earnings ratio than Precision BioSciences, indicating that it is currently the more affordable of the two stocks.
In the previous week, Turnstone Biologics had 1 more articles in the media than Precision BioSciences. MarketBeat recorded 1 mentions for Turnstone Biologics and 0 mentions for Precision BioSciences. Precision BioSciences' average media sentiment score of 0.00 equaled Turnstone Biologics'average media sentiment score.
Precision BioSciences currently has a consensus price target of $37.67, indicating a potential upside of 726.02%. Turnstone Biologics has a consensus price target of $2.13, indicating a potential upside of 377.53%. Given Precision BioSciences' stronger consensus rating and higher possible upside, research analysts clearly believe Precision BioSciences is more favorable than Turnstone Biologics.
Precision BioSciences has a net margin of 11.48% compared to Turnstone Biologics' net margin of 0.00%. Precision BioSciences' return on equity of -23.69% beat Turnstone Biologics' return on equity.
Precision BioSciences received 88 more outperform votes than Turnstone Biologics when rated by MarketBeat users. Likewise, 68.15% of users gave Precision BioSciences an outperform vote while only 50.00% of users gave Turnstone Biologics an outperform vote.
Summary
Precision BioSciences beats Turnstone Biologics on 12 of the 17 factors compared between the two stocks.
Get Turnstone Biologics News Delivered to You Automatically
Sign up to receive the latest news and ratings for TSBX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Turnstone Biologics Competitors List
Related Companies and Tools
This page (NASDAQ:TSBX) was last updated on 1/21/2025 by MarketBeat.com Staff
